SARS-CoV-2 Neutralizing Antibodies After Bivalent vs. Monovalent Booster
收藏官方服务：
资源简介：
SARS-CoV-2 Neutralizing Antibodies After Bivalent vs. Monovalent Booster
应用场景：
创建时间：
2023-02-14
相关数据集
DataSheet_3_Safety and Immunogenicity of an Inactivated COVID-19 Vaccine, WIBP-CorV, in Healthy Children: Interim Analysis of a Randomized, Double-Blind, Controlled, Phase 1/2 Trial.pdf
Safe and effective vaccines against SARS-CoV-2 for children are urgently needed. Here we aimed to assess the safety and immunogenicity of an inactivated COVID-19 vaccine candidate, WIBP-CorV, in parti
NIAID Data Ecosystem50
Characteristics of the study groups.
Influenza is especially dangerous for high-risk patients, for whom various vaccination strategies are used to prevent this disease. This study assessed the safety and immunological effectiveness of an
Figshare2025-09-18 更新20
DataSheet_1_Immunogenicity against wild-type and Omicron SARS-CoV-2 after a third dose of inactivated COVID-19 vaccine in healthy adolescents.pdf
IntroductionTwo doses of inactivated SARS-CoV-2 vaccine CoronaVac cannot elicit high efficacy against symptomatic COVID-19, especially against the Omicron variant, but that can be improved by a third
NIAID Data Ecosystem10
Vaccination with drifted variants of H5 hemagglutinin protein elicits a broadened antibody response
Assess the humoral response of mice immunized with drifted variant H5 hemagglutinin proteins
Immunology Database and Analysis Portal2025-10-30 更新20
Immunogenicity and Reactogenicity of Fractional vs. Full Booster Doses of COVID-19 Vaccines: A Non-Inferiority, Randomized, Double-Blind, Phase IV Clinical Trial in Pakistan
Background: Vaccine dose fractionation has been explored as a potential dose-sparing strategy to expand vaccine access. We conducted a randomized controlled trial to evaluate the immunogenicity and sa
DataCite Commons2025-07-07 更新20
